United States

Back to map

Showing 221-230 of 328 grants

Title Institution Researcher Program Duration Total Award Amount
Development of β-Cell Targeted Lipid Nanoparticle Therapeutics The University of Chicago Jacob Ryan Enriquez Cures 01-March-2025 to 29-February-2028 $247,790.00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2024 to 31-January-2026 $250,000.00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2025 to 31-January-2027 $1,000,000.00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease. The University of Chicago Piotr Witkowski Cures 01-September-2025 to 31-August-2029 $8,500,000.00
Engineered Nanoparticles for Beta Cell-Targeted Therapeutics The University of Chicago Raghavendra Mirmira Cures 01-April-2023 to 31-March-2026 $897,822.00
Role of β-cell Golgi dysfunction in Type 1 diabetes pathogenesis The University of Iowa Samuel Stephens Cures 01-June-2024 to 31-May-2027 $750,000.00
The Development of 3-β-hydroxybutyrate binding protein based electrochemical micro-sensor and its application for CKM system The University of North Carolina at Chapel Hill Koji Sode Improving Lives 01-October-2022 to 30-September-2025 $799,999.96
GABP regulation of human beta cell proliferation The University of Texas Health Science Center at Houston Richard Cox Cures 01-September-2024 to 31-August-2026 $200,000.00
Development of Low Cost, High Precision Nano Pumps for Insulin Delivery Torramics Inc. Sergey Gimelshein Improving Lives 01-March-2023 to 31-August-2026 $1,493,212.43
Achieving persistent presentation of self-antigens to reestablish tolerance and prevent autoimmune diabetes Trustees of Columbia University in the City of New York Camillo Bechi Genzano Cures 01-March-2025 to 29-February-2028 $256,285.00